ASTRAZENECA CANADA
AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development, and commercialization of medicines that transform lives. Our primary scientific focus is in Cardiovascular, Renal and Metabolic (CVRM) disease; Oncology; Rare Disease; Respiratory & Immunology; and Vaccine & Immune-Therapies. In 2023, AstraZeneca invested more than $230 million in Canadian health sciences research in our core therapy areas.
Across Canada, the company employs more than 2,300 people and recently announced a major expansion of more than 700 new highly-skilled jobs. This builds on its 2024 agreement to acquire Hamilton-based Fusion Pharmaceuticals in one of the largest research investments made in a Canadian biotechnology company and its 2023 announcement of more than 500 new scientific and high-tech jobs in the Greater Toronto Area.
AstraZeneca has been recognized as one of Canada’s Top 100 Employers 2024, one of Canada’s Most Admired Corporate Cultures 2024, and designated a Top Employer in the GTA for 10 consecutive years. For more information, please visit www.astrazeneca.ca
LEARN MORE:
Website: www.astrazeneca.ca
LinkedIn: @AstraZeneca
Instagram: @AstraZenecaCanada
BENEVA
Beneva is the country's largest mutual insurance company with 3.5 million members. Created by the coming together of La Capitale and SSQ Insurance in 2020, Beneva employs over 5,500 dedicated employees: people looking out for people. Its caring approach founded on human values and shared by its employees is anchored in its mutualist roots. With $27.5 billion in assets, Beneva has positioned itself as one of the leading Canadian companies in the insurance industry. It stands out for its diverse offerings in Group Insurance, Property and Casualty Insurance as well as Individual Insurance and Financial Services. Its head office is located in Quebec City.
LEARN MORE:
Website: beneva.ca
Beneva Tips and Tricks Blog: beneva.ca/en/blog
LinkedIn: Beneva
Facebook: Beneva
YouTube: Beneva
EXPRESS SCRIPTS CANADA
Express Scripts Canada (ESC) is a leading pharmacy benefit manager and healthcare solutions provider dedicated to improving health outcomes and optimizing pharmacy benefits for Canadians. ESC has been recognized as part of the most innovative pharmacy benefit manager (PBM) in the world. As industry leaders, innovation is at the forefront of everything we do.
ESC leverages innovative technology and a patient-centric approach to deliver comprehensive pharmacy management services. We are the only health benefits manager in Canada with the ability to tap into the resources of a global company that positively impacts the lives of more than 170 million people worldwide and tailor them to the Canadian market.
We are known for our best-in-class adjudication of pharmacy, dental and extended health claims, and industry-leading data analysis, which we turn into actionable insights for our clients in both the public and private sectors. Our clients include Canada’s leading insurers, third party administrators and government. We work with these clients to develop industry-leading solutions to deliver superior healthcare in a cost-controlled environment.
LEARN MORE:
Website: express-scripts.ca
LinkedIn: Express Scripts Canada
GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together.
Through our investment of over $2.8 billion in research and development in Canada over the past 25 years, we're constantly pushing the boundaries of science and technology to find new solutions for better health outcomes. From groundbreaking medicines to cutting-edge technologies, we’re working hard to develop innovations designed to prevent, treat, and transform lives.
LEARN MORE:
Website: www.gsk.ca
Mapol Vaccine Coverage Report Card 2025
INNOVATIVE MEDICINES CANADA
Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop and deliver innovative medicines and vaccines.
Our member companies, which range from early-stage startups to established organizations, are revolutionizing healthcare through the discovery and development of new medicines and vaccines.
Our industry supports 110,000 high-quality, well-paying jobs in Canada and invests $3.2 billion in R&D every year. Collectively, our activities contribute $18.4 billion per year to Canada’s knowledge-based economy.
Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and other stakeholders to advance the field of pharmaceutical research and development and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system.
We achieve our goals by forming alliances, supporting policies, improving Canada’s regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property.
We believe in ensuring that Canadians have access to the innovative treatments they need. Our activities are a fundamental part of safeguarding our healthcare system for future generations.
LEARN MORE:
Website: innovativemedicines.ca
X: @innovativemeds
Facebook: Innovative Medicines Canada
LinkedIn: Innovative Medicines Canada
CONTACT INFORMATION:
Joe Farago, executive director, market access, interim lead, government and stakeholders relations
jfarago@imc-mnc.ca
613-240-6871
PFIZER
Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines and vaccines. Pfizer’s ongoing research and development activities focus on a wide range of therapeutic areas following our guiding purpose: Breakthroughs that change patients’ livesTM.
LEARN MORE:
Website: pfizer.ca
LinkedIn: Pfizer
Facebook: Pfizer Canada
Twitter: @PfizerCA
Youtube: Pfizer Canada
Mapol Vaccine Coverage Report Card 2025
LUNDBECK CANADA
EN
Since 1995, Lundbeck Canada has been striving to improve the lives of Canadians living with brain diseases. As a subsidiary of H. Lundbeck A/S, a global pharmaceutical company specialized in brain diseases, we benefit from more than 70 years at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.
We are committed to fighting stigma and discrimination against people living with brain diseases and advocating for broader social acceptance of people with brain health conditions. Lundbeck’s research programs tackle some of the most complex challenges in neuroscience, and our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any, therapeutic options.
FR
Depuis 1995, Lundbeck Canada s'efforce d'améliorer la vie des Canadiens atteints de maladies du cerveau. En tant que filiale de H. Lundbeck A/S, une société pharmaceutique mondiale spécialisée dans les maladies du cerveau, nous bénéficions de plus de 70 ans d'expérience à l'avant-garde de la recherche neuroscientifique. Nous travaillons sans relâche pour rétablir la santé du cerveau, afin que chaque personne soit au mieux de sa forme.
Nous nous engageons à lutter contre la stigmatisation et la discrimination à l'égard des personnes atteintes de maladies du cerveau et à favoriser une meilleure acceptation sociale de ces dernières. Certains des défis les plus complexes en neurosciences sont relevés par les programmes de recherche de Lundbeck et notre pipeline se concentre sur la mise au point de traitements transformateurs pour les maladies du cerveau dont les options thérapeutiques sont peu nombreuses, voire inexistantes.
LEARN MORE:
Website: www.lundbeck.com/ca
MERCK
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
Chez Merck, connue sous le nom de MSD à l’extérieur des États-Unis et du Canada, nous sommes unis autour de notre raison d’être : nous utilisons la puissance des méthodes scientifiques de pointe pour sauver des vies et en améliorer partout dans le monde. Depuis plus d’un siècle, nous sommes à l’avant-garde des recherches, produisant des médicaments, des vaccins et des solutions de santé novatrices pour les maladies les plus éprouvantes au monde.
LEARN MORE:
Website: www.merck.ca
LinkedIn: Merck Canada
YouTube: Merck Canada
Twitter: @MerckCanada
Mapol Vaccine Coverage Report Card 2025
NOVO NORDISK
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.
We employ more than 65,000 people in 80 offices around the world, and market our products in 170 countries.
LEARN MORE:
Website: novonordisk.ca
LinkedIn: www.linkedin.com/company/novo-nordisk/
CONTACT INFORMATION:
Kanza Manzoor, Senior manager, Patient Access
knmq@novonordisk.com
DOWNLOAD PDF RESOURCE
DOWNLOAD PDF RESOURCE
GALDERMA
Galderma is the pure-play dermatology category leader, committed to advancing dermatology for every skin story. Leveraging our unique 40-year heritage of leading science-based innovation, we deliver a synergistic portfolio of flagship brands and services that span the full spectrum of dermatology.
LEARN MORE:
Website: www.galderma.com
Instagram: @galderma
LinkedIn: Galderma
X: @galderma
DOWNLOAD PDF RESOURCE
GREENSHIELD
As Canada's only national non-profit health and benefits company, GreenShield believes health care is a right, not a privilege. We're dedicated to improving health outcomes, driving systemic change, and building a future where every Canadian can reach their full health and well-being potential.
We are revolutionizing the health and benefits experience with coverage and care in one place. Through our unique integrated payer-provider ("payvider") model, offering insurance, administering benefits and paying claims as a 'payer' while offering health services such as mental health, pharmacy, telemedicine and chronic disease management as a 'provider'.
As a non-profit social enterprise, we don't have shareholders, which allows us to prioritize and reinvest our excess earnings to directly support underserved communities. Through GreenShield Cares, we've committed $75 million to improve the health of over one million Canadians by the end of 2025, focusing on mental health, essential medicines, and chronic disease management. Our scalable initiatives deliver meaningful change in pursuit of Better Health for All.
GreenShield is proud to be recognized as one of Canada's Most Admired Corporate Cultures, a leading Imagine Canada Caring Company, and named on the Fortune's Change the World list.
HEALTH SOLUTIONS BY SHOPPERS
Established in 2010, Health Solutions by Shoppers works collaboratively with Canada’s leading employers, insurance companies, and benefits advisors to drive innovation in benefits plan management and employee wellness.
Leveraging Shoppers Drug Mart and Loblaw’s strong industry partnerships, drug expertise, and unmatched retail assets, the Health Solutions by Shoppers team is committed to enabling employers to provide their employees with drug plan and health management solutions that are affordable and sustainable.
LEARN MORE:
Website: www.healthsolutions.ca
LinkedIn: @health solutions by shoppers
CONTACT INFORMATION:
Email: HealthSolutions@shoppersdrugmart.ca
INNOMAR STRATEGIES
Innomar Strategies, a part of Cencora, is the leading specialty service provider in the Canadian healthcare market. Regulatory and market access strategic consulting, quality assurance, safety, patient support programs, nursing, clinical services, and specialty pharmacy and logistics are just a few of our key services as part of our commitment to comprehensive solution delivery for our clients. We work closely with manufacturers, healthcare providers, and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to care, Innomar Strategies is united in our responsibility to create healthier futures.
LEARN MORE:
Website: www.innomar-strategies.com
LinkedIn: Innomar Strategies
CONTACT INFORMATION:
Jessica Lovett, Vice-President, Commercial Strategy, Innovation
jessica.lovett@cencora.com
DOWNLOAD PDF RESOURCE